Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Just massive

<< Previous

Bullboard Posts

Next >>

Comment by bringon10baggeron Jan 30, 2021 9:14am

172 Views

Post# 32427775

RE:RE:Just massive

Hey Doc, I'm of your opinion that ATE is on the sell block......Wallace/Legault academic buds probably not really interested in sterring this ship on another journey of commercialization but just be gratified to know a big pharma will change the world of pain/inflamm meds and they can be recognized for that......

Doccole wrote:
It really is...in addition this company is on the cusp of new drugs that can change the world.

I look forward to fining out the dilution hit on AH/ATE.
I hope a regional deal would provide enough cover to carry us until covid bs is over.
I can't wait for Nasdq.

Once this all occurs, I'll be very happy, and just sit back on my rocker and wait to be acquired.

finally, imho I feel like they want to sell the company. Hence getting the value up on the other drugs.